The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

We came across a bearish thesis on DocuSign, Inc. (DOCU) on Deep Value Returns’ Substack. In this article, we will summarize ...

DocuSign Inc. reported strong first-quarter of fiscal 2026 results while unveiling an artificial intelligence strategy.

DocuSign trimmed its full-year outlook for billing, after the closely-watched metric fell short of its guidance in the first quarter. The San Francisco e-signature company on Thursday posted a profit ...

DocuSign's growth has slowed post-pandemic, with revenue growth at 7.78% YoY in FY2025 and a slight dip in client count, raising concerns about ... lion’s share of the market 67% as of 2025.

Integration issues: Many potential IAM customers likely have existing ... expanding its total addressable market. If DocuSign successfully executes its IAM strategy, it could reignite growth rates and ...

Integration issues: Many potential IAM customers likely ... expanding its total addressable market. If DocuSign successfully executes its IAM strategy, it could reignite growth rates and establish ...

Shares of Docusign (DOCU ... maker gave weak sales guidance, raising concerns about EV demand in the Chinese market. Oil futures climbed. Gold prices set another record high.

In this article, we are going to take a look at where DocuSign, Inc. (NASDAQ ... and the growing competition in the global market in a CNBC interview on March 6. AI Advancements and the Importance ...

Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » On rare occasions, our expert team of analysts issues a “Double Down” stock ...